Guidelines for the correct use of the nomenclature of biochemical indices of bone status: a position statement of the Joint IOF Working Group and IFCC Committee on Bone Metabolism.

Autor: Lombardi G; Laboratory of Experimental Biochemistry, IRCCS Ospedale Galeazzi-Sant'Ambrogio, Milan, Italy.; Department of Athletics, Strength and Conditioning, Poznań University of Physical Education, Poznań, Poland., Jørgensen NR; Department of Clinical Biochemistry, Rigshospitalet, Copenhagen, Denmark.; Faculty of Health and Medical Sciences, Institute of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Harvey NC; MRC Lifecourse Epidemiology Centre, University of Southampton, Southampton, UK.; NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK., McCloskey EV; Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK.; Mellanby Centre for Musculoskeletal Research, MRC Versus Arthritis Centre for Integrated Research in Musculoskeletal Ageing, University of Sheffield, Sheffield, UK.; Centre for Metabolic Bone Diseases, University of Sheffield, Sheffield, UK., Åkesson KE; Department of Clinical Sciences, Clinical and Molecular Osteoporosis Research Unit, Lund University, Malmö, Sweden.; Department of Orthopaedics, Skåne University Hospital, Malmö, Sweden., Eastell R; Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK., Garnero P; INSERM Unit 1033, Edouard Herriot Hospital, Lyon, France., Kanis JA; Centre for Metabolic Bone Diseases, University of Sheffield, Sheffield, UK.; Mary McKillop Institute for Health Research, Australian Catholic University, Melbourne, Australia., Khashayar P; International Institute for Biosensing, University of Minnesota, Minneapolis, USA., Lane NE; Department of Medicine, Division of Rheumatology, U.C. Davis Health, Sacramento, CA, USA., McClung MR; Mary McKillop Institute for Health Research, Australian Catholic University, Melbourne, Australia.; Oregon Osteoporosis Center, Portland, OR, USA., Silverman S; Cedars-Sinai Medical Center and Geffen School of Medicine UCLA, Los Angeles, CA, USA., Makris K; Clinical Biochemistry Department, KAT General Hospital, Kifissia, Athens, Greece.; Laboratory for the Research of Musculoskeletal System 'Th. Garofalidis', School of Medicine, National and Kapodistrian, University of Athens, Athens, Greece., Bhattoa HP; Department of Laboratory Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Vasikaran SD; PathWest Laboratory Medicine, Fiona Stanley Hospital, Murdoch, WA, Australia., Pikner R; Department of Clinical Biochemistry and Bone Metabolism, Klatovska Hospital, Klatovy, Czech Republic.; Department of Clinical Biochemistry and Haematology, Faculty of Medicine Pilsen, Charles University Prague, Pilsen, Czech Republic.; Faculty of Health Care Studies, University of West Bohemia, Pilsen, Czech Republic., Cavalier E; Department of Clinical Chemistry, CIRM, University of Liège, CHU de Liège, Belgium.

Publikováno v: Clinical chemistry and laboratory medicine [Clin Chem Lab Med] 2024 Nov 25. Date of Electronic Publication: 2024 Nov 25.

The effects of denosumab on osteoclast precursors in postmenopausal women: a possible explanation for the overshoot phenomenon after discontinuation.

Autor: Schini M; Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, United Kingdom.; Sheffield Teaching Hospitals, NHS Foundation Trust, Sheffield, United Kingdom., Gossiel F; Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, United Kingdom., Saini T; Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, United Kingdom., Banda P; Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, United Kingdom., Ward R; Sheffield Teaching Hospitals, NHS Foundation Trust, Sheffield, United Kingdom., Vilaca T; Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, United Kingdom., Eastell R; Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, United Kingdom., Fontalis A; Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, United Kingdom.; Division of Surgery and Interventional Science, University College London, London, United Kingdom.

Publikováno v: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research [J Bone Miner Res] 2024 Oct 17. Date of Electronic Publication: 2024 Oct 17.

Goal-directed osteoporosis treatment: ASBMR/BHOF task force position statement 2024.

Autor: Cosman F; Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY 10032, United States., Lewiecki EM; New Mexico Clinical Research & Osteoporosis Center, Division of Metabolic Bone Diseases, Albuquerque, NM 87106, United States., Eastell R; Division of Clinical Medicine, University of Sheffield, Sheffield S10 2RX, United Kingdom., Ebeling PR; Department of Medicine, School of Clinical Sciences, Monash University, Clayton, VIC 3168, Australia., Jan De Beur S; Division of Endocrinology and Metabolism, University of Virginia, Charlottesville, VA 22908, United States., Langdahl B; Department of Endocrinology, Aarhus University Hospital, Aarhus N 8200, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus N 8200, Denmark., Rhee Y; Department of Internal Medicine, Severance Hospital, Endocrine Research Institute, Yonsei University College of Medicine, Seoul 03722, South Korea., Fuleihan GE; Calcium Metabolism and Osteoporosis Program, WHO Collaborating Center for Metabolic Bone Disorders, American University of Beirut, Beirut 1107, Lebanon., Kiel DP; Marcus Institute for Aging Research, Hebrew Senior Life, Boston, MA 02131, United States.; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, United States., Schousboe JT; Division of Research and Evaluation, HealthPartners Institute, Bloomington MN 55425, United States.; Division of Health Policy and Management, University of Minnesota, Minneapolis, MN 55425, United States., Borges JL; Brazil Clinical Research Center, Brasilia 71625-175, Brazil., Cheung AM; Department of Medicine and Joint Department of Medical Imaging, University Health Network, Toronto, ON M5G 2C4, Canada.; Centre of Excellence in Skeletal Health Assessment, University of Toronto, Toronto, ON M5G 2C4, Canada., Diez-Perez A; Department of Medicine, Institute Hospital del Mar of Medical Investigation, Barcelona 08003, Spain., Hadji P; Department of Obstetrics and Gynecology, Frankfurt Center of Bone Health and Phillipps-University of Marburg, Frankfurt 60313, Germany., Tanaka S; Department of Orthopaedic Surgery, Faculty of Medicine, The University of Tokyo, Hongo, Bunkyo-ku, Tokyo 113-0033, Japan., Thomasius F; Department of Clinical Osteology, Frankfurt Center of Bone Health and Endocrinology, Frankfurt 60313, Germany., Xia W; Department of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China., Cummings SR; San Francisco Coordinating Center, CPMC Research Institute, Department of Epidemiology and Biostatistics, University of California, San Francisco, CA 94158, United States.

Publikováno v: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research [J Bone Miner Res] 2024 Sep 26; Vol. 39 (10), pp. 1393-1405.

Proposed Denosumab Biosimilar SB16 vs Reference Denosumab in Postmenopausal Osteoporosis: Phase 3 Results Up to Month 12.

Autor: Langdahl B; Department of Endocrinology, Aarhus University Hospital and Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Chung YS; Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, Republic of Korea.; Institute on Aging, Ajou University Medical Center, Suwon, Republic of Korea., Plebanski R; Klinika Zdrowej Kosci, Lodz, Poland., Czerwinski E; Krakowskie Centrum Medyczne sp z oo, Krakow, Poland., Dokoupilova E; MEDICAL PLUS sro, Uherske Hradiste, Czech Republic.; Masaryk University, Faculty of Pharmacy, Department of Pharmaceutical Technology, Brno, Czech Republic., Supronik J; OsteoMedic sc A Racewicz J Supronik, Bialystok, Poland., Rosa J; Affidea Praha, s.r.o., Praha, Czech Republic., Mydlak A; ETG Siedlce, Siedlce, Poland., Rowińska-Osuch A; ETG Warszawa, Warszawa, Poland., Baek KH; Division of Endocrinology and Metabolism, Department of Internal Medicine, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea., Urboniene A; JSC Saules seimos medicinos centras, kaunas, Lithuania., Mordaka R; Santa Sp. z o.o., Lodz, Poland., Ahn S; Samsung Bioepis Co., Ltd., Incheon, Republic of Korea., Rho YH; Samsung Bioepis Co., Ltd., Incheon, Republic of Korea., Ban J; Samsung Bioepis Co., Ltd., Incheon, Republic of Korea., Eastell R; University of Sheffield, Sheffield, United Kingdom.

Publikováno v: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2024 Sep 07. Date of Electronic Publication: 2024 Sep 07.

Effects of High Dose Bolus Cholecalciferol on Free Vitamin D Metabolites, Bone Turnover Markers and Physical Function.

Autor: Bowles SD; Food and Nutrition Subject Group, Stoddart Building, Sheffield Hallam University, City Campus, Arundel Gate, Sheffield S1 1WB, UK.; MRC-Versus Arthritis Centre for Integrated Research into Musculoskeletal Ageing (CIMA), Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne NE2 4HH, UK., Jacques R; Medical Statistics Group, School of Health and Related Research (ScHARR), University of Sheffield, Regent Court, 30 Regent Street, Sheffield S1 4DA, UK., Hill TR; MRC-Versus Arthritis Centre for Integrated Research into Musculoskeletal Ageing (CIMA), Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.; Human Nutrition and Exercise Research Centre, Population Health Sciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne NE2 4HH, UK., Eastell R; MRC-Versus Arthritis Centre for Integrated Research into Musculoskeletal Ageing (CIMA), Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.; Division of Clinical Medicine, University of Sheffield, Sheffield S10 2RX, UK., Walsh JS; MRC-Versus Arthritis Centre for Integrated Research into Musculoskeletal Ageing (CIMA), Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.; Division of Clinical Medicine, University of Sheffield, Sheffield S10 2RX, UK.

Publikováno v: Nutrients [Nutrients] 2024 Aug 29; Vol. 16 (17). Date of Electronic Publication: 2024 Aug 29.